Nixoderm Unguento

Manufacturer
Laboratorios Incobra S.A.
Effective date
2016-02-10
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:44:56

Label at a glance#

ProductNixoderm Unguento
Active ingredientSALICYLIC ACID
Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active Ingredients:

Salicylic Acid 2%

OTC - PURPOSE SECTION

Acne Treatment

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, contact physician or poison control center immediately.

INDICATIONS & USAGE SECTION

For Skin Acne treatment

For relief, irritation, redness and of Acne

Indications:

*For the treatment of Acne.  Clears up acne pimples and blemishes, and allows skin to heal. Helpsprevent new pimples and blemishes from forming.

DOSAGE & ADMINISTRATION SECTION

Directions:

*Clean the skin thoroughly before applying this product.

*Cover the entire affected area with a thing layer one to three times daily, then gradually increase to two or three time daily if needed or as directed by a doctor

*If bothersome dryness or peeling occurs, reduce application to once a day or every other day

WARNINGS SECTION

Warnings:

*For external use only.

*Avoid contact with eyes. If contact occurs, rinse thoroughly with water

When using this product

*Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use only topical acne medication at a time

*Do not use without consulting a doctor if the condition appears over a large portion of the body.

Store at room temperature.

INACTIVE INGREDIENT SECTION

Other Ingredients: beeswax, BHT, benzoic acid, petrolatum, polysorbate 80, sulfur, zinc oxide.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image descriptionimage description

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
251400salicylic acid 2 % Topical OintmentPSN1
251400salicylic acid 0.02 MG/MG Topical OintmentSCD1
251400salicylic acid 2 % Topical OintmentSY1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c6f86816-7da6-43ea-8c25-ac9758311cc5Product name120220118
252e11b6-1a9a-4283-a242-df2c129c496dProduct name320170717

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70344-001-012020-01-31C16284748780-19d75b9d0-e260-f424-e053-dadaa90a57ce528e48cb-9f36-4717-896c-0bae3d997e6e

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70344-001-01Nixoderm Unguento20 g in 1 PACKAGEOINTMENT201

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70344-001NIXODERM UNGUENTO (SALICYLIC ACID) OINTMENT [LABORATORIOS INCOBRA S.A.]1Legacy NDC, 1 package rows20160211_528e48cb-9f36-4717-896c-0bae3d997e6e.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
70344-00170344-001-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
d03a2040-5af8-4fc0-bbbe-825345c0782e528e48cb-9f36-4717-896c-0bae3d997e6e2016-02-10WarningsExact identifier
spl id: d03a2040-5af8-4fc0-bbbe-825345c0782e
spl set id: 528e48cb-9f36-4717-896c-0bae3d997e6e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.